CLAIMBOUND / SOURCE-PUBLICATION EVIDENCE
Clinical trials
Every card identifies what it proves, what it does not prove, its exact quote, locator, source hash, and local rerun command.
1. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 8
Narrow public claim
Clinical trials conducted in accordance with this standard will help to assure that the rights, safety and well-being of trial participants are protected; that the conduct is consistent with the principles that have their origin in the Declaration of Helsinki; and that the clinical trial results are reliable.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 8- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Clinical trials conducted in accordance with this standard will help to assure that the rights, safety and well-being of trial participants are protected; that the conduct is consistent with the principles that have their origin in the Declaration of Helsinki; and that the clinical trial results are reliable.2. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 8
Narrow public claim
Guideline Scope This guideline applies to interventional clinical trials of investigational products1 that are intended to be submitted to regulatory authorities.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 8- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Guideline Scope This guideline applies to interventional clinical trials of investigational products1 that are intended to be submitted to regulatory authorities.3. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 9
Narrow public claim
The principles outlined in this guideline may be satisfied using differing approaches and should be applied to fit the intended purpose of the clinical trial.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 9- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The principles outlined in this guideline may be satisfied using differing approaches and should be applied to fit the intended purpose of the clinical trial.4. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 9
Narrow public claim
Annex 1, including its Appendices, is intended to provide information on how the Principles can be appropriately applied to clinical trials.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 9- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Annex 1, including its Appendices, is intended to provide information on how the Principles can be appropriately applied to clinical trials.5. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 10
Narrow public claim
The principles are interdependent and should be considered in their totality to assure ethical trial conduct and reliable results.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 10- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The principles are interdependent and should be considered in their totality to assure ethical trial conduct and reliable results.6. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 10
Narrow public claim
The participant selection process should be representative of the population groups that the investigational product is intended to benefit, once authorised, to allow for generalising the results across the broader population.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 10- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The participant selection process should be representative of the population groups that the investigational product is intended to benefit, once authorised, to allow for generalising the results across the broader population.7. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 11
Narrow public claim
For potential participants unable to provide informed consent, their legally acceptable representatives, acting in the participants’ best interest, should provide consent prior to clinical trial participation.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 11- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
For potential participants unable to provide informed consent, their legally acceptable representatives, acting in the participants’ best interest, should provide consent prior to clinical trial participation.8. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 11
Narrow public claim
In the event that a minor is a participant, assent should be collected from that minor, as appropriate, and in accordance with local regulatory requirements (see ICH E11(R1) Clinical Investigation of Medicinal Products in the Pediatric Population).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 11- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In the event that a minor is a participant, assent should be collected from that minor, as appropriate, and in accordance with local regulatory requirements (see ICH E11(R1) Clinical Investigation of Medicinal Products in the Pediatric Population).9. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 12
Narrow public claim
Individuals involved in a trial should be qualified by education, training and experience to perform their respective task(s).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 12- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Individuals involved in a trial should be qualified by education, training and experience to perform their respective task(s).10. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 12
Narrow public claim
These factors are attributes of a trial that are fundamental to the protection of participants, the reliability and interpretability of the trial results and the decisions made based on those trial results.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 12- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t01_primary_claims.json --source-file <local-raw-pdf>Exact source quote
These factors are attributes of a trial that are fundamental to the protection of participants, the reliability and interpretability of the trial results and the decisions made based on those trial results.11. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 13
Narrow public claim
9.3 Computerised systems used in clinical trials should be fit for purpose (e.g., through risk-based validation, if appropriate), and factors critical to their quality should be addressed in their design or adaptation for clinical trial purposes to ensure the integrity of relevant trial data.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 13- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
9.3 Computerised systems used in clinical trials should be fit for purpose (e.g., through risk-based validation, if appropriate), and factors critical to their quality should be addressed in their design or adaptation for clinical trial purposes to ensure the integrity of relevant trial data.12. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 13
Narrow public claim
These essential records should be available to regulatory authorities, monitors, auditors and IRBs/IECs (as appropriate) upon request to enable appropriate evaluation of the trial conduct in order to ensure the reliability of trial results.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 13- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
These essential records should be available to regulatory authorities, monitors, auditors and IRBs/IECs (as appropriate) upon request to enable appropriate evaluation of the trial conduct in order to ensure the reliability of trial results.13. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 14
Narrow public claim
Where activities have been transferred or delegated to service providers, the responsibility for the conduct of the trial, including quality and integrity of the trial data, resides with the sponsor or investigator, respectively.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 14- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Where activities have been transferred or delegated to service providers, the responsibility for the conduct of the trial, including quality and integrity of the trial data, resides with the sponsor or investigator, respectively.14. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 15
Narrow public claim
For the submission to or communication with the IRB/IEC, in most regions where there is also a requirement to make a submission to the relevant regulatory authority, these may be combined in a single submission in accordance with applicable regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 15- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
For the submission to or communication with the IRB/IEC, in most regions where there is also a requirement to make a submission to the relevant regulatory authority, these may be combined in a single submission in accordance with applicable regulatory requirements.15. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 15
Narrow public claim
Submissions and communications with the IRB/IEC and regulatory authorities are made in some regions by the investigator/institution and by the sponsor in other regions in accordance with applicable regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 15- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Submissions and communications with the IRB/IEC and regulatory authorities are made in some regions by the investigator/institution and by the sponsor in other regions in accordance with applicable regulatory requirements.16. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 16
Narrow public claim
Payments to a participant should be timely, prorated and not wholly contingent on completion of the trial by the participant.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 16- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Payments to a participant should be timely, prorated and not wholly contingent on completion of the trial by the participant.17. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 16
Narrow public claim
It is recommended that the IRB/IEC should include: (a) At least five members; (b) At least one member whose primary area of interest is not in medical sciences; (c) At least one member who is independent of the institution/investigator site.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 16- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
It is recommended that the IRB/IEC should include: (a) At least five members; (b) At least one member whose primary area of interest is not in medical sciences; (c) At least one member who is independent of the institution/investigator site.18. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 19
Narrow public claim
The investigator may be supported by the sponsor in the identification of a suitable service provider(s); however, the investigator retains the final decision on whether the service provider intended to support the investigator is appropriate based on information provided by the sponsor (see section 3.6.5).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 19- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The investigator may be supported by the sponsor in the identification of a suitable service provider(s); however, the investigator retains the final decision on whether the service provider intended to support the investigator is appropriate based on information provided by the sponsor (see section 3.6.5).19. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 19
Narrow public claim
The investigator retains the ultimate responsibility and should maintain appropriate oversight of the persons or parties undertaking the activities delegated to ensure the rights, safety and well-being of the trial participants and the reliability of data.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 19- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The investigator retains the ultimate responsibility and should maintain appropriate oversight of the persons or parties undertaking the activities delegated to ensure the rights, safety and well-being of the trial participants and the reliability of data.20. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 20
Narrow public claim
In addition to those identified by the investigator themselves, protocol deviations relevant to their trial participants and their conduct of the trial may be communicated to them by the sponsor (see section 3.11.4.5.1(b)).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 20- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t02_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In addition to those identified by the investigator themselves, protocol deviations relevant to their trial participants and their conduct of the trial may be communicated to them by the sponsor (see section 3.11.4.5.1(b)).21. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 20
Narrow public claim
In either case, the investigator should review the deviations, and for those deviations deemed important, the investigator should explain the deviation and implement appropriate measures to prevent a recurrence, where applicable (see section 3.9.3).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 20- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In either case, the investigator should review the deviations, and for those deviations deemed important, the investigator should explain the deviation and implement appropriate measures to prevent a recurrence, where applicable (see section 3.9.3).22. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 21
Narrow public claim
(a) A qualified physician or, where appropriate, a qualified dentist (or other qualified healthcare professionals in accordance with local regulatory requirements) who is an investigator or a sub-investigator for the trial should have the responsibility for trial-related medical care and decisions.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 21- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(a) A qualified physician or, where appropriate, a qualified dentist (or other qualified healthcare professionals in accordance with local regulatory requirements) who is an investigator or a sub-investigator for the trial should have the responsibility for trial-related medical care and decisions.23. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 21
Narrow public claim
(b) Other appropriately qualified healthcare professionals may be involved in the medical care of trial participants, in line with their normal activities and in accordance with local regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 21- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(b) Other appropriately qualified healthcare professionals may be involved in the medical care of trial participants, in line with their normal activities and in accordance with local regulatory requirements.24. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 22
Narrow public claim
(b) All serious adverse events (SAEs) should be reported immediately (after the investigator reasonably becomes aware of the event) to the sponsor.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 22- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(b) All serious adverse events (SAEs) should be reported immediately (after the investigator reasonably becomes aware of the event) to the sponsor.25. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 22
Narrow public claim
In accordance with applicable regulatory requirements, the protocol may identify SAEs not requiring immediate reporting; for example, deaths or other events that are endpoints.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 22- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In accordance with applicable regulatory requirements, the protocol may identify SAEs not requiring immediate reporting; for example, deaths or other events that are endpoints.26. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 23
Narrow public claim
(e) Whether the informed consent process takes place in person or remotely, the investigator should assure themselves of the identity of the participant (or legally acceptable representative) in accordance with applicable regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 23- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(e) Whether the informed consent process takes place in person or remotely, the investigator should assure themselves of the identity of the participant (or legally acceptable representative) in accordance with applicable regulatory requirements.27. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 23
Narrow public claim
The communication of this information and confirmation of the willingness to continue trial participation should be documented.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 23- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The communication of this information and confirmation of the willingness to continue trial participation should be documented.28. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 24
Narrow public claim
The informed consent process may involve a physical or an electronic signature and date (see the glossary term “signature”).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 24- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The informed consent process may involve a physical or an electronic signature and date (see the glossary term “signature”).29. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 24
Narrow public claim
When prior consent of the participant is not possible and the participant’s legally acceptable representative is not available, enrolment of the participant should require measures described in the protocol and/or elsewhere, with documented approval/favourable opinion by the IRB/IEC, to protect the participant’s rights, safety and well-being and to ensure compliance with applicable regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 24- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
When prior consent of the participant is not possible and the participant’s legally acceptable representative is not available, enrolment of the participant should require measures described in the protocol and/or elsewhere, with documented approval/favourable opinion by the IRB/IEC, to protect the participant’s rights, safety and well-being and to ensure compliance with applicable regulatory requirements.30. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 26
Narrow public claim
During trial participation, the participant or the participant’s legally acceptable representative should receive a copy of the consent form updates and any other updated informed consent materials provided.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 26- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t03_primary_claims.json --source-file <local-raw-pdf>Exact source quote
During trial participation, the participant or the participant’s legally acceptable representative should receive a copy of the consent form updates and any other updated informed consent materials provided.31. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 26
Narrow public claim
A process for consent should be considered if, during the course of the trial, the minor reaches the age of legal consent, in accordance with applicable regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 26- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
A process for consent should be considered if, during the course of the trial, the minor reaches the age of legal consent, in accordance with applicable regulatory requirements.32. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 27
Narrow public claim
The investigator or delegated investigator site staff should consider explaining to the participant the value of continuing their participation to minimise trial participants withdrawal.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 27- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The investigator or delegated investigator site staff should consider explaining to the participant the value of continuing their participation to minimise trial participants withdrawal.33. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 27
Narrow public claim
In this process, the investigator should ensure that it does not interfere with the participant’s decision to refuse or withdraw participation at any time.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 27- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
In this process, the investigator should ensure that it does not interfere with the participant’s decision to refuse or withdraw participation at any time.34. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 29
Narrow public claim
The investigator should review and endorse the reported data at important milestones agreed upon with the sponsor (e.g., interim analysis) (see section 3.16.1(o)).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 29- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The investigator should review and endorse the reported data at important milestones agreed upon with the sponsor (e.g., interim analysis) (see section 3.16.1(o)).35. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 33
Narrow public claim
(a) Where reference is made to a submission to the IRB/IEC, this can be made by the investigator/institution or sponsor in accordance with applicable regulatory requirements (see section 1.1).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 33- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(a) Where reference is made to a submission to the IRB/IEC, this can be made by the investigator/institution or sponsor in accordance with applicable regulatory requirements (see section 1.1).36. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 34
Narrow public claim
The sponsor should adopt a proportionate and riskbased approach to quality management, which involves incorporating quality into the design of the clinical trial (i.e., quality by design) and identifying those factors that are likely to have a meaningful impact on participants’ rights, safety and well-being and the reliability of the results (i.e., critical to quality factors as described in ICH E8(R1)).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 34- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The sponsor should adopt a proportionate and riskbased approach to quality management, which involves incorporating quality into the design of the clinical trial (i.e., quality by design) and identifying those factors that are likely to have a meaningful impact on participants’ rights, safety and well-being and the reliability of the results (i.e., critical to quality factors as described in ICH E8(R1)).37. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 34
Narrow public claim
The sponsor should describe the quality management approach implemented in the trial in the clinical trial report (see ICH E3 Structure and Content of Clinical Study Reports).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 34- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The sponsor should describe the quality management approach implemented in the trial in the clinical trial report (see ICH E3 Structure and Content of Clinical Study Reports).38. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 36
Narrow public claim
The sponsor should summarise and report important quality issues (including instances in which acceptable ranges are exceeded, as detailed in section 3.10.1.3) and the remedial actions taken and document them in the clinical trial report (see ICH E3).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 36- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The sponsor should summarise and report important quality issues (including instances in which acceptable ranges are exceeded, as detailed in section 3.10.1.3) and the remedial actions taken and document them in the clinical trial report (see ICH E3).39. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 36
Narrow public claim
When performed, audits should be conducted in a manner that is proportionate to the risks associated with the conduct of the trial (see section 3.10.1.1).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 36- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
When performed, audits should be conducted in a manner that is proportionate to the risks associated with the conduct of the trial (see section 3.10.1.1).40. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 39
Narrow public claim
(a) Selecting the site and confirming that the investigator and individuals or parties involved in the trial conduct have adequate qualifications, resources (see sections 2.1, 2.2 and 3.7) and facilities, including laboratories, equipment and investigator site staff, to conduct the trial safely and properly.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 39- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t04_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(a) Selecting the site and confirming that the investigator and individuals or parties involved in the trial conduct have adequate qualifications, resources (see sections 2.1, 2.2 and 3.7) and facilities, including laboratories, equipment and investigator site staff, to conduct the trial safely and properly.41. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 40
Narrow public claim
(d) Confirming that informed consent was obtained before participation in the trial (see section 2.8) for trial participants at the site.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 40- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(d) Confirming that informed consent was obtained before participation in the trial (see section 2.8) for trial participants at the site.42. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 43
Narrow public claim
(b) The sponsor should, in accordance with the applicable regulatory requirement(s) and with ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, expedite the reporting to the regulatory authority(ies) of all suspected, unexpected and serious adverse reactions (i.e., SUSARs).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 43- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(b) The sponsor should, in accordance with the applicable regulatory requirement(s) and with ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting, expedite the reporting to the regulatory authority(ies) of all suspected, unexpected and serious adverse reactions (i.e., SUSARs).43. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 44
Narrow public claim
Alternatively, for authorised medicinal products, the sponsor should identify the basic product information to be used in the trial (see Appendix A, section A.1.1).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 44- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Alternatively, for authorised medicinal products, the sponsor should identify the basic product information to be used in the trial (see Appendix A, section A.1.1).44. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 47
Narrow public claim
(e) The sponsor should ensure that documented processes are implemented to ensure the data integrity for the full data life cycle (see section 4.2).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 47- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(e) The sponsor should ensure that documented processes are implemented to ensure the data integrity for the full data life cycle (see section 4.2).45. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 47
Narrow public claim
This enables the investigators to make decisions (e.g., on eligibility, treatment, continuing participation in the trial and care for the safety of the individual trial participants) (see section 2.12.3).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 47- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
This enables the investigators to make decisions (e.g., on eligibility, treatment, continuing participation in the trial and care for the safety of the individual trial participants) (see section 2.12.3).46. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 48
Narrow public claim
These steps may vary depending on the purpose of the analysis to be conducted (e.g., data for IDMC, for interim analysis or the final analysis) (see section 4.2.6).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 48- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
These steps may vary depending on the purpose of the analysis to be conducted (e.g., data for IDMC, for interim analysis or the final analysis) (see section 4.2.6).47. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 51
Narrow public claim
(b) The sponsor should ensure that trial participants have consented to direct access to source records for the purposes outlined in 3.16.4(a) (see section 2.8.10(n)).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 51- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(b) The sponsor should ensure that trial participants have consented to direct access to source records for the purposes outlined in 3.16.4(a) (see section 2.8.10(n)).48. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 51
Narrow public claim
The sponsor should also ensure that the clinical trial reports in marketing applications meet the standards of ICH E3 or are otherwise in accordance with applicable regulatory requirements.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 51- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
The sponsor should also ensure that the clinical trial reports in marketing applications meet the standards of ICH E3 or are otherwise in accordance with applicable regulatory requirements.49. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 55
Narrow public claim
As described in sections 2 and 3, the responsibilities of the sponsor, investigator and the activities of other parties with respect to a computerised system used in clinical trials should be clear and documented.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 55- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
As described in sections 2 and 3, the responsibilities of the sponsor, investigator and the activities of other parties with respect to a computerised system used in clinical trials should be clear and documented.50. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 59
Narrow public claim
INVESTIGATOR’S BROCHURE A.1 Introduction The Investigator’s Brochure (IB) is a compilation of the clinical and nonclinical data on the investigational product(s)1 that are relevant to the study of the product(s) in human participants.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 59- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t05_primary_claims.json --source-file <local-raw-pdf>Exact source quote
INVESTIGATOR’S BROCHURE A.1 Introduction The Investigator’s Brochure (IB) is a compilation of the clinical and nonclinical data on the investigational product(s)1 that are relevant to the study of the product(s) in human participants.51. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 59
Narrow public claim
A.1.1 Development of the Investigator’s Brochure Generally, the sponsor is responsible for ensuring that an up-to-date IB is developed.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 59- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
A.1.1 Development of the Investigator’s Brochure Generally, the sponsor is responsible for ensuring that an up-to-date IB is developed.52. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 61
Narrow public claim
A.3.4 Physical, Chemical and Pharmaceutical Properties and Formulation A description should be provided of the investigational product substance(s) (including the chemical and/or structural formula(e)), and a brief summary should be given of the relevant physical, chemical and pharmaceutical properties.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 61- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
A.3.4 Physical, Chemical and Pharmaceutical Properties and Formulation A description should be provided of the investigational product substance(s) (including the chemical and/or structural formula(e)), and a brief summary should be given of the relevant physical, chemical and pharmaceutical properties.53. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 61
Narrow public claim
A.3.5 Nonclinical Studies Introduction The results of all relevant nonclinical pharmacology, toxicology, pharmacokinetic and investigational product metabolism studies should be provided in summary form.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 61- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
A.3.5 Nonclinical Studies Introduction The results of all relevant nonclinical pharmacology, toxicology, pharmacokinetic and investigational product metabolism studies should be provided in summary form.54. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 65
Narrow public claim
B.2.2 A summary of findings from nonclinical studies that potentially have clinical significance and from clinical trials that are relevant to the trial.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 65- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.2.2 A summary of findings from nonclinical studies that potentially have clinical significance and from clinical trials that are relevant to the trial.55. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 65
Narrow public claim
B.2.5 A statement that the trial will be conducted in compliance with the protocol, Good Clinical Practice (GCP) and the applicable regulatory requirement(s).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 65- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.2.5 A statement that the trial will be conducted in compliance with the protocol, Good Clinical Practice (GCP) and the applicable regulatory requirement(s).56. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 66
Narrow public claim
B.4.2 A description of the type and design of trial to be conducted (e.g., double-blind, placebo-controlled, parallel design, adaptive design, platform/umbrella/basket, trials with decentralised elements) and a schematic diagram of trial design, procedures and stages.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 66- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.4.2 A description of the type and design of trial to be conducted (e.g., double-blind, placebo-controlled, parallel design, adaptive design, platform/umbrella/basket, trials with decentralised elements) and a schematic diagram of trial design, procedures and stages.57. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 66
Narrow public claim
B.4.3 A description of the measures taken to minimise/avoid bias, including: (a) Randomisation (b) Blinding B.4.4 A description of the investigational product(s) and the dosage and dosage regimen of the investigational product(s), including a description of the dosage form, packaging and labelling.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 66- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.4.3 A description of the measures taken to minimise/avoid bias, including: (a) Randomisation (b) Blinding B.4.4 A description of the investigational product(s) and the dosage and dosage regimen of the investigational product(s), including a description of the dosage form, packaging and labelling.58. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 67
Narrow public claim
Conversely, the participant may decide to withdraw from the trial or stop treatment with the investigational product (see sections 2.8.10(l), 2.8.10(m) and 2.9.1).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 67- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Conversely, the participant may decide to withdraw from the trial or stop treatment with the investigational product (see sections 2.8.10(l), 2.8.10(m) and 2.9.1).59. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 67
Narrow public claim
B.7 Treatment and Interventions for Participants B.7.1 The treatment(s) to be administered, including the name(s) of all the product(s), the dose(s), the dosing schedule(s), the criteria for dose adjustment(s), the route/mode(s) of administration and the treatment period(s), including the follow-up period(s) for participants for each investigational product treatment/trial treatment group/arm of the trial.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 67- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.7 Treatment and Interventions for Participants B.7.1 The treatment(s) to be administered, including the name(s) of all the product(s), the dose(s), the dosing schedule(s), the criteria for dose adjustment(s), the route/mode(s) of administration and the treatment period(s), including the follow-up period(s) for participants for each investigational product treatment/trial treatment group/arm of the trial.60. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 68
Narrow public claim
B.10 Statistical Considerations B.10.1 A description of the statistical methods to be employed, including timing and purpose of any planned interim analysis(ses) and the statistical criteria for the stopping of the trial.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 68- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t06_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.10 Statistical Considerations B.10.1 A description of the statistical methods to be employed, including timing and purpose of any planned interim analysis(ses) and the statistical criteria for the stopping of the trial.61. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 68
Narrow public claim
B.10.2 The number of participants planned to be enrolled and the reason for the choice of sample size, including reflections on or calculations of the power of the trial and clinical justification.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 68- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.10.2 The number of participants planned to be enrolled and the reason for the choice of sample size, including reflections on or calculations of the power of the trial and clinical justification.62. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 69
Narrow public claim
B.14.2 The identification of data to be recorded directly into the data acquisition tools (i.e., no prior written or electronic record of data) and considered to be the source record.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 69- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
B.14.2 The identification of data to be recorded directly into the data acquisition tools (i.e., no prior written or electronic record of data) and considered to be the source record.63. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 70
Narrow public claim
C.2 Management of Essential Records C.2.1 Records should be identifiable and version controlled (when appropriate) and should include authors, reviewers and approvers as appropriate, along with date and signature (electronic or physical), where necessary.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 70- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
C.2 Management of Essential Records C.2.1 Records should be identifiable and version controlled (when appropriate) and should include authors, reviewers and approvers as appropriate, along with date and signature (electronic or physical), where necessary.64. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 70
Narrow public claim
C.2.2 For activities that are transferred or delegated to service providers by the sponsor or investigator/institution, respectively, arrangements should be made for the access and management of the essential records throughout the trial and for their retention following completion of the trial.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 70- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
C.2.2 For activities that are transferred or delegated to service providers by the sponsor or investigator/institution, respectively, arrangements should be made for the access and management of the essential records throughout the trial and for their retention following completion of the trial.65. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 71
Narrow public claim
C.2.6 The sponsor and investigator/institution should retain the essential records in a way that ensures that they remain complete, readable and readily available and are directly accessible upon request by regulatory authorities, monitors and auditors.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 71- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
C.2.6 The sponsor and investigator/institution should retain the essential records in a way that ensures that they remain complete, readable and readily available and are directly accessible upon request by regulatory authorities, monitors and auditors.66. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 71
Narrow public claim
C.2.7 The sponsor and investigator/institution should ensure the retention of the essential records required to fulfil their responsibility.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 71- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
C.2.7 The sponsor and investigator/institution should ensure the retention of the essential records required to fulfil their responsibility.67. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 73
Narrow public claim
C.3.2 Applying the criteria in section C.3.1, the trial records that are considered essential are listed in the Essential Records Table, and these should be retained when produced.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 73- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
C.3.2 Applying the criteria in section C.3.1, the trial records that are considered essential are listed in the Essential Records Table, and these should be retained when produced.68. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 74
Narrow public claim
C.3.3 For some trial records listed in the Essential Record Table, their presence and nature are dependent on the trial design, trial conduct and risk proportionate management of the trial and may not be produced.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 74- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
C.3.3 For some trial records listed in the Essential Record Table, their presence and nature are dependent on the trial design, trial conduct and risk proportionate management of the trial and may not be produced.69. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 77
Narrow public claim
(see ICH E2A) An important medical event that may not be immediately life-threatening or result in death or hospitalisation, that may jeopardise the participant or that may require intervention to prevent serious outcomes (see ICH E2A and E19) should generally be considered as serious.
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 77- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
(see ICH E2A) An important medical event that may not be immediately life-threatening or result in death or hospitalisation, that may jeopardise the participant or that may require intervention to prevent serious outcomes (see ICH E2A and E19) should generally be considered as serious.70. ICH E6(R3) Guideline for Good Clinical Practice · PDF page 79
Narrow public claim
Clinical Trial/Study Report (CSR) A documented description of a trial of any investigational product conducted in human participants, in which the clinical and statistical description, presentations and analyses are fully integrated into a single report (see ICH E3 Structure and Content of Clinical Study Reports).
What this card proves
The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.
What this card does not prove
It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.
- Primary source
- ICH E6(R3) Guideline for Good Clinical Practice
- Section locator
PDF page 79- Captured
- 2026-08-11
- Source SHA-256
e6ce19e36ce7d2e294f89ee89492b9e035178c3cca48984392bbd92eec9b002c- Reproduction
- Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally
Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.
python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom019_t07_primary_claims.json --source-file <local-raw-pdf>Exact source quote
Clinical Trial/Study Report (CSR) A documented description of a trial of any investigational product conducted in human participants, in which the clinical and statistical description, presentations and analyses are fully integrated into a single report (see ICH E3 Structure and Content of Clinical Study Reports).